Diabetes News and Research

Latest Diabetes News and Research

Big Ow awareness campaign

When it comes to symptoms of menopause like hot flashes, weight gain or trouble sleeping, chances are most women wouldn't hesitate to speak to their doctor. But there is another common - and equally distressing - effect of menopause that many women just keep to themselves. The Big Ow, also known as vaginal atrophy, will affect as many as two million Canadian women in the next 10 years - but most are too shy or embarrassed to talk about it, even with their doctor.

8 Feb 2010

Athlete hopes for first U.S. cross-country medal; health issues plagued 2006 Olympic bid

Kris Freeman is back in the hunt for an Olympic medal in Vancouver after being named today to the U.S. ski team following a disappointing finish at the 2006 Games in Torino, Italy.

6 Feb 2010

Artificial pancreas can help manage diabetes in kids overnight

In a landmark study in children and teenagers with type 1 diabetes, JDRF-funded researchers at the University of Cambridge showed that using a first-generation artificial pancreas system overnight can lower the risk of low blood sugar emergencies while sleeping, and at the same time improve diabetes control.

6 Feb 2010

Cardiologists recommend tips to prevent heart disease

There's a lot you can do to reduce your risk of heart disease and improve your chances for a longer, healthier life. Cardiologists from The Polyclinic in Seattle recommend that you first, learn more about some of the risk factors for heart disease.

6 Feb 2010

EVMS researchers identify source that causes Type 1 diabetes

Doctors at Eastern Virginia Medical School's Strelitz Diabetes Center have been stalking the culprit responsible for Type 1 diabetes. Now, they are one step closer.

5 Feb 2010

Access Pharmaceuticals initiates Cobalamin technology program for targeted delivery of siRNA therapies

ACCESS PHARMACEUTICALS, INC. announced today that it initiated an internal pre-licensing program to confirm the utility of its proprietary Cobalamin (vitamin B12) platform technology for targeted delivery of siRNA therapies. The program is considered important because, despite the widely publicized potential of RNA therapy, researchers up to now have been stymied in their efforts to design a pharmaceutical product that efficiently transports siRNA therapeutics into the cells they are designed to inhibit or kill.

5 Feb 2010

Pazopanib drug slows the progression of RCC in patients by 54%

The drug pazopanib (Votrient) slowed the progression of advanced renal cell carcinoma (RCC), a form of kidney cancer, in patients by 54% percent, according to a new study published in the Journal of Clinical Oncology.

5 Feb 2010

TGen completes strategic alliance and affiliation agreement with VARI

The Translational Genomics Research Institute (TGen) today announced the completion of a strategic alliance and affiliation agreement with the Van Andel Research Institute (VARI) that will maximize the research capabilities of both non-profit institutes.

5 Feb 2010

CCHP implements TriZetto systems to improve its network and health management programs

The TriZetto Group, Inc. today announced that Chinese Community Health Plan (CCHP) has successfully implemented several TriZetto systems, including the Facets®, NetworX Pricer® and Clinical CareAdvance® applications.

5 Feb 2010

Patients with mild gallstone pancreatitis can be operated within 48 hours of admission

Patients with mild gallstone pancreatitis usually stay in the hospital for several days, waiting for the symptoms to subside, before undergoing surgery to remedy the condition. A new study from researchers at Los Angeles Biomedical Research Institute (LA BioMed) indicates patients may no longer have to wait so long for surgery and could leave the hospital sooner.

5 Feb 2010

Merck announces $1.5M funding commitment over three years to BC Centre for Excellence in HIV/AIDS

Today, Merck is pleased to announce its $1.5 million funding commitment over three years to the BC Centre for Excellence in HIV/AIDS (BC-CfE) in support of its research program entitled "Seek and Treat for Optimal Prevention of HIV/AIDS", known as the "seek & treat" program, which will expand HIV treatment and care for hard-to-reach residents in Prince George and Vancouver's Downtown Eastside.

5 Feb 2010

Vanderbilt Heart and Vascular Institute offers new blood test to predict heart disease

Just in time for American Heart Month, Vanderbilt Heart and Vascular Institute is offering a new blood test that can predict if a patient is at high risk for heart disease. Vanderbilt is among the first institutions in the country, and the only one in Tennessee, to offer this test.

5 Feb 2010

Anthem Blue Cross introduces DailyMed Pharmacy program for Medi-Cal members

Imagine having to face the daily struggle of taking six or more different medications a day to manage a chronic health condition; add to this the worry of missing or taking a dose incorrectly. For Anthem Blue Cross (Anthem) Medi-Cal members, that daily struggle will now be simplified to help increase medication adherence and reduce medication errors.

5 Feb 2010

Prehistoric data suggests link between tooth enamel defects and early mortality

Ancient human teeth are telling secrets that may relate to modern-day health: Some stressful events that occurred early in development are linked to shorter life spans.

5 Feb 2010

American Heart Month aims to spread awareness of women and heart disease

More than five times as many women are diagnosed with heart disease each year than with breast cancer. American Heart Month in February aims to spread awareness of women and heart disease, and one Alabama company has found the quickest way to a woman's heart might be through her gynecologist.

5 Feb 2010

Alkermes develops proprietary LinkeRx technology platform to create injectable antipsychotics

Alkermes, Inc. today announced that it has developed a novel, proprietary LinkeRx™ technology platform to enable the creation of injectable extended-release versions of antipsychotics and other central nervous system (CNS) therapies.

4 Feb 2010

Texas Health Dallas offers heart and vascular screening program for women

When Mary Gill went to bed that night, nothing would have made anyone think heart disease — not even Mary. She was thin and 42 years old. She exercised regularly, ate a healthy diet and never smoked.

4 Feb 2010

First annual Translational Regenerative Medicine Forum in Winston-Salem

The Regenerative Medicine Foundation today announced the first annual Translational Regenerative Medicine Forum to be held April 6-8, 2010 at the Benton Convention Center in Winston-Salem.

4 Feb 2010

Around seven in every thousand morbidly obese people are missing part of their DNA

A small but significant proportion of morbidly obese people are missing a section of their DNA, according to research published today in Nature. The authors of the study, from Imperial College London and ten other European Centres, say that missing DNA such as that identified in this research may be having a dramatic effect on some people's weight.

4 Feb 2010

Defective chromosome cause of severe obesity

A new cause of obesity due to a defect on chromosome 16 has just been discovered. It is thought to explain close to 1% of obesity cases. For carriers of the defect, the risk of becoming overweight is 50 times higher. This research is the result of close cooperation between the team of Professor Froguel, a CNRS researcher, in Lille, and colleagues at Imperial College in London and Vaudois University Hospital in Lausanne, with the support of ten other European research groups. The findings of the study are to be published in Nature on February 4, 2010.

4 Feb 2010

Diabetes News and Research

Latest Diabetes News and Research

Big Ow awareness campaign

Athlete hopes for first U.S. cross-country medal; health issues plagued 2006 Olympic bid

Artificial pancreas can help manage diabetes in kids overnight

Cardiologists recommend tips to prevent heart disease

EVMS researchers identify source that causes Type 1 diabetes

Access Pharmaceuticals initiates Cobalamin technology program for targeted delivery of siRNA therapies

Pazopanib drug slows the progression of RCC in patients by 54%

TGen completes strategic alliance and affiliation agreement with VARI

CCHP implements TriZetto systems to improve its network and health management programs

Patients with mild gallstone pancreatitis can be operated within 48 hours of admission

Merck announces $1.5M funding commitment over three years to BC Centre for Excellence in HIV/AIDS

Vanderbilt Heart and Vascular Institute offers new blood test to predict heart disease

Anthem Blue Cross introduces DailyMed Pharmacy program for Medi-Cal members

Prehistoric data suggests link between tooth enamel defects and early mortality

American Heart Month aims to spread awareness of women and heart disease

Alkermes develops proprietary LinkeRx technology platform to create injectable antipsychotics

Texas Health Dallas offers heart and vascular screening program for women

First annual Translational Regenerative Medicine Forum in Winston-Salem

Around seven in every thousand morbidly obese people are missing part of their DNA

Defective chromosome cause of severe obesity

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Diabetes News and Research

Latest Diabetes News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in